Exchange: NASDAQ·Updated 07:37 PM EDT

TNGX Tango Therapeutics Inc

$23.49
$1.94
(7.67%)
Today
Closed $23.34
$0.15
(0.64%)
After Hours
Reported EarningsAug 11
Mkt Cap$3.94B
Vol2M

About TNGX

Tango Therapeutics, Inc. is a clinical-stage biotechnology company, which engages in discovering and delivering precision cancer medicines. It also identifies novel targets and develops new drugs directed at tumor suppressor gene loss in defined patient populations with high unmet medical need. The company was founded by Alan Ashworth, William G. Kaelin Jr., Jose Baselga, Antoni Ribas and Barbara Weber in 2017 and is headquartered in Boston, MA.
60

Bullish Sentiment

How do you feel about TNGX?

Advertisement|Remove ads.